Geneva, Switzerland, 2 September 2011 – Addex Pharmaceuticals (SIX:ADXN), a leading biopharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today …
Addex Pharmaceuticals First Half 2011 Financial Results
Geneva, Switzerland, 27 July 2011 – Addex Pharmaceuticals (SIX: ADXN), a leader in allosteric modulation-based drug discovery and development, announced today financial results for the first half of …
Addex Announces Corporate Reorganization and Restructuring Initiative to Strengthen Its Leadership Position in Allosteric Modulation-Based Drug Discovery and Development
Focus on Core R&D Programs Goals Include: Increased Operational Efficiency, Strategic Partnerships with Industry Leaders Geneva, Switzerland, 7 July 2011 - Allosteric modulation company Addex …
Addex Pharmaceuticals CEO Steps Down
Geneva, Switzerland, 3 June 2011 – Allosteric modulation company Addex Pharmaceuticals Ltd (SIX:ADXN) announced today that Vincent Mutel, PhD, has stepped down from his position as CEO of the Addex …
Addex Shareholders Appoint Hoyoung Huh and Oleg Nodelman to Board, Approve All Board Proposals at Annual General Meeting
Geneva, Switzerland, 28 April 2011 - Allosteric modulation company Addex Pharmaceuticals Ltd (SIX:ADXN) announced that its shareholders approved all the proposals of the board of directors at its 2011 …
Addex Initiates Phase IIa Clinical Trial of Dipraglurant-IR in Parkinson’s Disease Levodopa-Induced Dyskinesia (PD-LID)
• Clinically validated mechanism of action for PD-LID • Second Phase IIa trial to begin this quarter with Addex allosteric modulators • Trial funded in part by Michael J. Fox Foundation for …
Addex Partner Starting Clinical Schizophrenia Trial
Geneva, Switzerland, March 28, 2011 – Allosteric modulation company Addex Pharmaceuticals (SIX:ADXN) announced today the start of a Phase IIa clinical trial of ADX71149 for the treatment of …
Addex Converts Mandatory Convertible Notes and Issues Ordinary Shares
Geneva, Switzerland, 14 March, 2011 – Allosteric modulation company Addex Pharmaceuticals (SIX:ADXN) announced today that further to the Company’s press release dated 14 September 2010, the …
Addex Board Proposes Hoyoung Huh and Oleg Nodelman for Election to the Board of Directors
Geneva, Switzerland, 9 March 2011 – Allosteric modulation company Addex Pharmaceuticals (SIX:ADXN) announced today that the Board of Directors proposes to the Annual General Meeting of 28 April 2011 …
Addex Pharmaceuticals 2010 Financial Results
Geneva, Switzerland, 23 February 2011 – Allosteric modulation company Addex Pharmaceuticals (SIX:ADXN) announced today 2010 financial results and reviewed the status of its pipeline. The results will …